Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Galer

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Archives of Physical Medicine and Rehabilitation|December 23, 1998
Neuropathic pain in Charcot-Marie-Tooth diseaseG T Carter, M P Jensen, B S Galer, et al.
Epilepsia|October 22, 2021
Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysisJoseph Sullivan, Nicola Specchio, Orrin Devinsky, et al.
Pain|October 27, 1999
Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?R N Harden, S Bruehl, B S Galer, et al.
Pain|June 3, 1999
External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of PainS Bruehl, R N Harden, B S Galer, et al.
Archives of Neurology|September 1, 1987
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.
Epilepsy & Behavior : E&B|May 23, 2021
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndromeKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Neurology|December 11, 2002
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic painM S Wallace, M C Rowbotham, N P Katz, et al.
Seizure|November 12, 2021
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndromeJ Helen Cross, Bradley S Galer, Antonio Gil-Nagel, et al.
Bioinformatics (Oxford, England)|July 23, 2003
The binding interface database (BID): a compilation of amino acid hot spots in protein interfacesT B Fischer, K V Arunachalam, D Bailey, et al.
Pain|February 21, 2012
Response to "A new definition of neuropathic pain"Anne Louise Oaklander, Peter R Wilson, Peter A Moskovitz, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Archives of Physical Medicine and Rehabilitation|December 23, 1998
Neuropathic pain in Charcot-Marie-Tooth diseaseG T Carter, M P Jensen, B S Galer, et al.
Epilepsia|October 22, 2021
Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysisJoseph Sullivan, Nicola Specchio, Orrin Devinsky, et al.
Pain|October 27, 1999
Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?R N Harden, S Bruehl, B S Galer, et al.
Pain|June 3, 1999
External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of PainS Bruehl, R N Harden, B S Galer, et al.
Archives of Neurology|September 1, 1987
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.
Epilepsy & Behavior : E&B|May 23, 2021
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndromeKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Neurology|December 11, 2002
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic painM S Wallace, M C Rowbotham, N P Katz, et al.
Seizure|November 12, 2021
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndromeJ Helen Cross, Bradley S Galer, Antonio Gil-Nagel, et al.
Bioinformatics (Oxford, England)|July 23, 2003
The binding interface database (BID): a compilation of amino acid hot spots in protein interfacesT B Fischer, K V Arunachalam, D Bailey, et al.
Pain|February 21, 2012
Response to "A new definition of neuropathic pain"Anne Louise Oaklander, Peter R Wilson, Peter A Moskovitz, et al.
Pageof 13